Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.29 CNY -4.61% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Kanion Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Cash from Operating Activities
ÂĄ975.4m
CAGR 3-Years
15%
CAGR 5-Years
3%
CAGR 10-Years
9%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Operating Activities
ÂĄ3.1B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Operating Activities
ÂĄ1.2B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
17%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Operating Activities
ÂĄ7.9B
CAGR 3-Years
39%
CAGR 5-Years
19%
CAGR 10-Years
18%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Operating Activities
ÂĄ4.5B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Operating Activities
-ÂĄ615.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Kanion Pharmaceutical Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Pharmaceuticals

Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.

Intrinsic Value
23.69 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
975.4m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 975.4m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
9%

Over the last year, the Cash from Operating Activities growth was -9%. The average annual Cash from Operating Activities growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been 15% over the past three years , 3% over the past five years , and 9% over the past ten years .

Back to Top